Wellington Management Group
RVMD icon

Wellington Management Group’s Revolution Medicines RVMD Stock Holding History

Wellington Management Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$720M Sell
3,843,415
-2,184,404
-36% -$319M 0.12% 173
2026
Q1 		$586M Sell
6,027,819
-959,820
-14% -$96.9M 0.11% 189
2025
Q4 		$557M Sell
6,987,639
-2,825,797
-29% -$185M 0.1% 193
2025
Q3 		$458M Sell
9,813,436
-446,302
-4% -$17.5M 0.08% 217
2025
Q2 		$377M Sell
10,259,738
-1,528,183
-13% -$58.7M 0.07% 234
2025
Q1 		$417M Buy
11,787,921
+966,230
+9% +$39.2M 0.08% 210
2024
Q4 		$473M Sell
10,821,691
-579,703
-5% -$29.3M 0.09% 196
2024
Q3 		$517M Sell
11,401,394
-2,258,802
-17% -$98.4M 0.09% 197
2024
Q2 		$530M Sell
13,660,196
-1,054,530
-7% -$39.4M 0.09% 200
2024
Q1 		$474M Sell
14,714,726
-167,360
-1% -$4.96M 0.08% 230
2023
Q4 		$427M Buy
14,882,086
+4,309,611
+41% +$104M 0.08% 237
2023
Q3 		$293M Buy
10,572,475
+282,786
+3% +$8.39M 0.06% 291
2023
Q2 		$275M Sell
10,289,689
-135,679
-1% -$3.33M 0.05% 326
2023
Q1 		$226M Buy
10,425,368
+1,551,394
+17% +$38.2M 0.04% 367
2022
Q4 		$211M Buy
8,873,974
+1,492,795
+20% +$31.7M 0.04% 372
2022
Q3 		$146M Buy
7,381,179
+1,212,177
+20% +$26.6M 0.03% 434
2022
Q2 		$120M Buy
6,169,002
+2,085,013
+51% +$40.6M 0.02% 492
2022
Q1 		$104M Sell
4,083,989
-426,906
-9% -$9.29M 0.02% 574
2021
Q4 		$114M Sell
4,510,895
-26,207
-0.6% -$739K 0.02% 598
2021
Q3 		$125M Sell
4,537,102
-1,041,946
-19% -$30.3M 0.02% 560
2021
Q2 		$177M Buy
5,579,048
+1,658,400
+42% +$57.9M 0.03% 469
2021
Q1 		$180M Buy
3,920,648
+3,688,457
+1,589% +$165M 0.03% 444
2020
Q4 		$9.19M Buy
232,191
+28,352
+14% +$1.12M ﹤0.01% 1206
2020
Q3 		$7.09M Sell
203,839
-78,902
-28% -$2.19M ﹤0.01% 1185
2020
Q2 		$8.93M Sell
282,741
-53,924
-16% -$1.7M ﹤0.01% 1094
2020
Q1 		$7.38M Buy
+336,665
New +$9.32M ﹤0.01% 1113

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Wellington Management Group's RVMD Position: Q2 2026 in Review

Wellington Management Group reduced its Revolution Medicines (RVMD) stake by 36% in Q2 2026, selling an estimated $319M and leaving 3,843,415 shares worth $720M. The position accounts for 0.12% of the portfolio, ranked #173.

Wellington Management Group first reported a position in RVMD in Q1 2020 and has held it in 26 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Wellington Management Group held 3,843,415 shares of Revolution Medicines worth $720M as of Q2 2026.
  • Wellington Management Group sold 2,184,404 Revolution Medicines shares in Q2 2026, an estimated $319M.
  • Revolution Medicines made up 0.12% of Wellington Management Group's portfolio in Q2 2026, its #173 holding.
  • Wellington Management Group first reported a position in Revolution Medicines in Q1 2020 and has held it in 26 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.